PACSCAN: Chest CT-scan for the Diagnosis of Community-acquired Pneumonia
Study Details
Study Description
Brief Summary
Primary objective : to estimate impact of CT-scan on diagnostic for emergency department (ED) patients with suspected Community-acquired Pneumonia (CAP).
Secondary objective: to estimate impact of CT-scan on treatment (antimicrobial therapy) and site of care for ED patients with suspected CAP.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Rational: Community-acquired pneumonia (CAP) is a frequent infectious disorder in patients visiting the ED. CAP is responsible for high morbidity and associated-mortality is increasing in Western countries. CAP corresponds to invasion of the lung by pathogens. Diagnosis depends on clinical and X-ray assessment. However, these signs and symptoms are poorly specific and are often lacking. As prognosis depends on precocious and fitted antimicrobial treatment, making CAP diagnosis in a short time span (4-8 hours) is mandatory. Preliminary studies suggest that chest CT-scan could over-performed X-ray for diagnosis of CAP. Consensus conferences suggest the use of CT-scan in patients with uncertain diagnosis and unusual presentation and outcome. Because CT-scan is currently easily available, its use in a first intent is questionable for ED patients with suspected CAP.
Primary objective: to estimate impact of CT-scan on diagnostic for ED patients with suspected CAP.
Secondary objective: to estimate impact of CT-scan on treatment (antimicrobial therapy) and site of care for ED patients with suspected CAP.
Prospective multicenter study to measure chest CT-scan impact. 350 patients visiting the ED of 4 inner tertiary teaching hospitals in Paris, France, with suspected CAP.
Management: Patients will be managed according to current guidelines, including conventional chest X-ray.
Evaluation criteria. Attending ED physicians will implement pre- and post-test proforma for diagnosis (CAP) level of certainty, treatment (antimicrobial agents), site of care, before and after chest CT-scan. Comparison of ED physician's answers before/after CT-scan. Patients will be followed until day 28. An adjudication committee (1 pneumologist, 1 infectiologist, 1 radiologist)will review patients' data for gold standard diagnosis.
Statistical considerations: The investigators hypothesize that chest CT-scan wil modify diagnosis certainty in 20%. This implies that 300 participants should be enrolled to allow assessment of changes in 15 % et 25 %. Undue changes will be calculated a posteriori when diagnosis gold standard will be established by adjudication committee.
Anticipated results: Chest CT-scan should improve diagnosis certainty, treatment and site-of-care in patients visiting the ED with suspected CAP. If this is observed in at least 20%, the investigators will measure impact of chest CT-scan in a prospective randomized interventional study.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Chest CT-scan Patients with a suspicion of acquired pneumonia visiting the emergency department will do a chest CT-scan |
Procedure: Chest CT-scan
Patients with a suspicion of acquired pneumonia visiting the emergency department will do a chest CT-scan
|
Outcome Measures
Primary Outcome Measures
- Chest CT-scan [in 28 days]
Percentage of diagnoses modified by chest CT-scan.
Secondary Outcome Measures
- Treatments changes [in 28 days]
Percentage of treatments changes (antimicrobial therapy) modified by chest CT-scan
- Changes of site-of-care [in 28 days]
Percentage of site-of-care (admission/non admission) modified by chest CT-scan
- Identification of viral and bacterial agents [at day of inclusion (day 1)]
Identification of viral and bacterial agents from nasal and pharyngeal swabs
- Markers of infection in the blood [at day of inclusion (day 1)]
Determination of markers of infection in the blood
- Markers of infection and markers of inflammation in urine [at day of inclusion (day 1)]
Determination of markers of infection and of inflammation in urine
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Patient above 18 years of age
-
Patient with a presumptive diagnosis of CAP according to attending ED physician
-
Patient experiencing at least one systemic sign (T°>38°C or < 36°C, HR>90/min, RR>20/min)
-
Patient experiencing one respiratory sign (cough, lateral chest pain, localized crackles, dyspnea) that recently appeared
-
Patient with a prior medical examination, the results have been or will be communicated
-
Patient gave written informed consent or in cases of emergency parent/ support person who gave written informed consent if he/she is present on the day of inclusion
Exclusion Criteria:
-
Pregnancy
-
Patient with shock
-
Patient with respiratory distress and immune suppression
-
Patient with other criteria for immediate ICU referral to ICU
-
Patient with living conditions making it impossible to follow 28 days
-
Patient not affiliated with a social security system
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | La Pitié Salpêtrière Hospital | Paris | France | 75013 | |
2 | Cochin Hospital | Paris | France | 75014 | |
3 | Bichat Hospital | Paris | France | 75018 | |
4 | Tenon Hospital | Paris | France | 75020 |
Sponsors and Collaborators
- Assistance Publique - Hôpitaux de Paris
Investigators
- Principal Investigator: Yann-Erick Claessens, MD, PhD, Cochin Hospital, Paris, France
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- AOM10014
- P100121